Amgen (AMGN) Shares Issued (2009 - 2015)
Amgen (AMGN) recorded quarterly Shares Issued of $17.0 million in Q4 2015, up 30.77% quarter-over-quarter from $13.0 million in Q3 2015, and down 48.48% on a YoY basis from $33.0 million in Q4 2014.
Amgen (AMGN) Shares Issued (2009 - 2015) Analysis & Trends
Amgen's Shares Issued history runs 7 years deep, the most recent figure standing at $17.0 million for Q4 2015.
- In Q4 2015, Shares Issued fell 48.48% year-over-year to $17.0 million; the TTM figure through Dec 2015 stood at $82.0 million (down 55.91% YoY), while the FY2016 annual figure was $55.0 million, down 32.93% from the prior year.
- Shares Issued was $17.0 million for Q4 2015 at Amgen, up from $13.0 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $545.0 million in Q3 2012 to a low of $13.0 million in Q3 2011.
- Historically, Shares Issued has averaged $104.7 million across 5 years, with a median of $55.0 million in 2013.
- The sharpest annual moves came in 2012 and 2013: Shares Issued soared 4092.31% in 2012, then tumbled 89.72% in 2013.
- A 5-year view of Shares Issued shows it stood at $116.0 million in 2011, then surged by 37.07% to $159.0 million in 2012, then tumbled by 82.39% to $28.0 million in 2013, then gained by 17.86% to $33.0 million in 2014, then plunged by 48.48% to $17.0 million in 2015.
- The last three Shares Issued figures came in at $17.0 million (Q4 2015), $13.0 million (Q3 2015), and $34.0 million (Q2 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 17.00 Mn |
| Dec 31, 2015 | 17.00 Mn |
| Sep 30, 2015 | 13.00 Mn |
| Sep 30, 2015 | 13.00 Mn |
| Jun 30, 2015 | 34.00 Mn |
| Jun 30, 2015 | 34.00 Mn |
| Mar 31, 2015 | 18.00 Mn |
| Mar 31, 2015 | 18.00 Mn |
| Dec 31, 2014 | 33.00 Mn |
| Dec 31, 2014 | 33.00 Mn |
| Sep 30, 2014 | 54.00 Mn |
| Sep 30, 2014 | 54.00 Mn |
| Jun 30, 2014 | 61.00 Mn |
| Jun 30, 2014 | 61.00 Mn |
| Mar 31, 2014 | 38.00 Mn |
| Mar 31, 2014 | 38.00 Mn |
| Dec 31, 2013 | 28.00 Mn |
| Dec 31, 2013 | 28.00 Mn |
| Sep 30, 2013 | 56.00 Mn |
| Sep 30, 2013 | 56.00 Mn |